In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Martin Landray
Speaker
Martin Landray
Martin Landray Martin Landray

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)

Speciality : Pharmacology and Pharmacotherapy

Martin Landray is Professor of Medicine & Epidemiology at the Nuffield Department of Population Health, University of Oxford, UK. He is Interim Director of the Big Data Institute & leads the clinical trials programme for Health Data Research UK. His research focuses on the use of digital technology and quality-by-design principles for large randomized trials of treatments for cardiovascular, including the SHARP, THRIVE, REVEAL, & ORION-4. He is co-chief investigator of the RECOVERY trial, which has enrolled over 12,000 hospitalised patients with COVID-19. The trial produced 3 practice-changing results: neither hydroxychloroquine nor lopinavir-ritonavir improve clinical outcomes; by contrast dexamethasone reduces mortality by one-third among patients on ventilators. He is a member of the European Society of Cardiology Regulatory Affairs Committee & leads the Good Clinical Trials Collaborative supported by Wellcome, Gates Foundation, and African Academy of Science.

5 presentations from this speaker

COVID 19 Trial Update

Event : ESC Congress 2020

  • Session : COVID and Cardiovascular Disease
  • Speaker : MJ Landray (Oxford,GB)

COVID and Cardiovascular Diseases - European Perspective.

Event : ESC Asia 2020

  • Session : COVID and Cardiovascular Diseases
  • Speaker : MJ Landray (Oxford,GB)

Online Session on COVID and Cardiovascular Disease - Host and Discussant

Event : ESC Congress 2020

  • Session : COVID and Cardiovascular Disease
  • Speaker : MJ Landray (Oxford,GB)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now
logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are